Business
CSL (ASX:CSL) share price wobbles on plasma and vaccine update
The CSL Limited (ASX: CSL) share price has been in the spotlight in recent memory. This follows concerns over its plasma collections as well as its progress in producing the AstraZeneca COVID-19 vaccine.
At the time of writing, the global biotech’s shares are trading for $264.64, down 1.3% for the day.
Plasma worries
COVID-19 has wreaked havoc on the global economy and virtually shut down foot traffic movement in the United States.
Unfortunately for CSL, this has affected its plasma collections as fewer people are donating blood to its collection centres. The company last provided an update in March advising that December 2020 plasma volumes…
-
Noosa News16 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General23 hours agoMinecraft mayhem: ‘Chicken jockey’ chaos reaches Australian cinemas
-
General17 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News19 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate